Clinical Trial Update: Supporting Weak Immune System During Autoimmune Therapy: Testing Panzyga to Prevent Infections [Phase 3]

View source ↗

Summary

Phase 3 trial update evaluating Panzyga to prevent infections in patients with hypogammaglobulinemia receiving autoimmune therapy. The study is not yet recruiti…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Diseases
• Hypogammaglobulinemia
• Infectious Diseases
• Rheumatic Diseases

Drugs mentioned

• Panzyga (intravenous immunoglobulin)

Snippet

Sponsor: Octapharma | Conditions: Hypogammaglobulinemia, Autoimmune Conditions | Phase 3 | Status: NOT_YET_RECRUITING